Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|February 20, 2014
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study GroupLev Shvidel, Tamar Tadmor, Andrei Braester, et al.
Annals of Hematology|May 25, 2012
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patientsLev Shvidel, Andrei Braester, Osnat Bairey, et al.
Plos One|January 3, 2019
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activityRegina Michelis, Tamar Tadmor, Masad Barhoum, et al.
Frontiers in Immunology|March 1, 2021
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic LeukemiaNaseba Naseraldeen, Regina Michelis, Masad Barhoum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2010
TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent mannerInbal Binsky, Frida Lantner, Valentin Grabovsky, et al.
Hematological Oncology|February 14, 2019
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experienceYair Herishanu, Tamar Tadmor, Andrei Braester, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 16, 2020
Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and CarnitineKalman Filanovsky, Michal Haran, Vita Mirkin, et al.
Blood|December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccinationYair Herishanu, Galia Rahav, Shai Levi, et al.
American Journal of Hematology|August 12, 2014
Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study GroupTamar Tadmor, Lev Shvidel, Osnat Bairey, et al.
Anticancer Research|February 11, 2014
Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study groupTamar Tadmor, Lev Shvidel, Neta Goldschmidt, et al.
Pageof 6